Inhibition of rat brain protein and nucleic acid synthesis by cannabinoids in vitro.
D000375:Aging; D000818:Animals; D000831:Animals, Newborn; D002188:Cannabis / Q000494:pharmacology*; D002245:Carbon Dioxide / Q000096:biosynthesis; D002247:Carbon Isotopes; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism*; D003864:Depression, Chemical; D013759:Dronabinol / Q000494:pharmacology; D066298:In Vitro Techniques; D007700:Kinetics; D007930:Leucine / Q000378:metabolism; D008297:Male; D009419:Nerve Tissue Proteins / Q000096:biosynthesis*; D009696:Nucleic Acids / Q000096:biosynthesis*; D010101:Oxygen Consumption / Q000187:drug effects; D011188:Potassium / Q000494:pharmacology; D011526:Protoveratrines / Q000494:pharmacology; D051381:Rats; D013268:Stimulation, Chemical; D014498:Uracil / Q000096:biosynthesis; D014500:Uracil Nucleotides / Q000096:biosynthesis; D014529:Uridine / Q000378:metabolism
D002247:Carbon Isotopes; D009419:Nerve Tissue Proteins; D009696:Nucleic Acids; D011526:Protoveratrines; D014500:Uracil Nucleotides; D002245:Carbon Dioxide; D014498:Uracil; D013759:Dronabinol; D007930:Leucine; D011188:Potassium; D014529:Uridine